Edwards Lifesciences Overview

  • Year Founded
  • 1958

Year Founded

  • Status
  • Public

  • Employees
  • 19,800

Employees

  • Stock Symbol
  • EW

Stock Symbol

  • Investments
  • 38

  • Share Price
  • $88.52
  • (As of Tuesday Closing)

Edwards Lifesciences General Information

Description

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.

Contact Information

Website
www.edwards.com
Formerly Known As
Edwards Laboratories, American Edwards Laboratories, Cvg Controlled Inc
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Other Devices and Supplies
Stock Exchange
NYS
Corporate Office
  • One Edwards Way
  • Irvine, CA 92614
  • United States
+1 (949) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Edwards Lifesciences Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$88.52 $86.87 $60.57 - $96.12 $53.3B 603M 2.7M $2.33

Edwards Lifesciences Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 56,639,915 45,142,425 45,076,516 79,771,934
Revenue 6,143,400 6,004,800 5,382,400 5,232,500
EBITDA 1,699,600 1,693,400 1,890,700 1,837,800
Net Income 1,413,800 1,402,400 1,521,900 1,503,100
Total Assets 9,736,300 9,363,200 8,292,500 8,502,600
Total Debt 699,200 694,900 691,300 690,300
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Edwards Lifesciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Edwards Lifesciences‘s full profile, request access.

Request a free trial

Edwards Lifesciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical d
Surgical Devices
Irvine, CA
19,800 As of 2023
00.000
000000000 00.000

000000

quip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptat
00000000 0000000
Princeton, NJ
0000 As of 0000
00.00
000000000 00 00.00

000000

t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
00000000 0000000
Portage, MI
00000 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edwards Lifesciences Competitors (45)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Integra Lifesciences Corporation Princeton, NJ 0000 00.00 000000000 00 00.00
Stryker Formerly VC-backed Portage, MI 00000 000.00 000000000 000.00
Boston Scientific Corporation Marlborough, MA 00000 000.00 000000000 00 000.00
Zimmer Biomet Holdings Corporation Warsaw, IN 00000 000.00 000000000 00 000.00
Teleflex Corporation Wayne, PA 00000 00.000 000000000 00.000
You’re viewing 5 of 45 competitors. Get the full list »

Edwards Lifesciences Patents

Edwards Lifesciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240115381-A1 Steerable delivery apparatus for an implantable medical device Pending 07-Oct-2022 0000000000
US-20240020092-A1 Contactless control of physiological monitors Pending 14-Jul-2022 000000000 0
US-20230414215-A1 Trigger-based tissue anchor deployment Pending 23-Jun-2022 00000000000
US-20230390538-A1 Cardiac shunt device to minimize disruption and enhance natural flow patterns of blood through the heart Pending 07-Jun-2022 0000000000
US-20240024109-A1 Enhancing positional adjustment of devices that are delivered via a catheter Pending 17-Feb-2022 A61F2/2466
To view Edwards Lifesciences’s complete patent history, request access »

Edwards Lifesciences Executive Team (38)

Name Title Board Seat Contact Info
Bernard Zovighian Chief Executive Officer and Board of Directors
Larry Wood Corporate Vice President, Transcatheter Aortic Valve Replacement
Scott Ullem Chief Financial Officer, Finance & Vice President
Robert Sellers VP, Corporate Controller
Steve Cohen Director, Corporate Strategy
You’re viewing 5 of 38 executive team members. Get the full list »

Edwards Lifesciences Board Members (16)

Name Representing Role Since
0000000 000000000 Edwards Lifesciences Chief Executive Officer and Board of Directors 000 0000
000000 00000000 Self Board Member 000 0000
000000 00000 Self Board Member 000 0000
00000000 000000000 Self Board Member & Member of its Compensation and Governance Committee 000 0000
0000 0000000000 Self Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Edwards Lifesciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Edwards Lifesciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Edwards Lifesciences‘s full profile, request access.

Request a free trial

Edwards Lifesciences Investments & Acquisitions (38)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Restore Medical 01-Mar-2022 00000 0000 00.00 Therapeutic Devices
V-Wave 22-Sep-2020 00000 0000 0000 Therapeutic Devices
Caption Care 15-Jul-2020 00000 0000 0000 Other Healthcare Technology Systems
Caption Care 28-Apr-2020 00000 0000 Other Healthcare Technology Systems
Fore-Sight Elite 18-Apr-2019 Merger/Acquisition 00000 Monitoring Equipment 000000000
You’re viewing 5 of 38 investments and acquisitions. Get the full list »

Edwards Lifesciences Subsidiaries (2)

Company Name Industry Location Founded
Valtech Cardio Therapeutic Devices Or Yehuda, Israel 2005
Edwards Lifesciences 401(k) Savings and Investment Plan Corporate Pension Irvine, CA 0000
To view Edwards Lifesciences’s complete subsidiaries history, request access »

Edwards Lifesciences ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

22.12 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,191

Rank

00.00

Percentile

Healthcare

Industry

00 of 643

Rank

00.00

Percentile

Medical Devices

Subindustry

00 of 229

Rank

00.00

Percentile

To view Edwards Lifesciences’s complete esg history, request access »

Edwards Lifesciences Exits (15)

Company Name Exit Date Exit Type Exit Size Status Buyers
Caption Care 15-Jul-2020 00000 00000 00 0000 Completed
  • 12 buyers
Caption Care 28-Apr-2020 00000 00000 00 Completed
  • 3 buyers
Cardiovalve 01-Feb-2017 00000 00000 00 0000 Completed
  • 6 buyers
CardioKinetix 08-Dec-2014 00000 00000 00 0000 Completed
  • 9 buyers
Middle Peak Medical 26-Jun-2013 Early Stage VC 000.00 Completed
  • 5 buyers
You’re viewing 5 of 15 exits. Get the full list »

Edwards Lifesciences FAQs

  • When was Edwards Lifesciences founded?

    Edwards Lifesciences was founded in 1958.

  • Who is the CEO of Edwards Lifesciences?

    Bernard Zovighian is the CEO of Edwards Lifesciences.

  • Where is Edwards Lifesciences headquartered?

    Edwards Lifesciences is headquartered in Irvine, CA.

  • What is the size of Edwards Lifesciences?

    Edwards Lifesciences has 19,800 total employees.

  • What industry is Edwards Lifesciences in?

    Edwards Lifesciences’s primary industry is Surgical Devices.

  • Is Edwards Lifesciences a private or public company?

    Edwards Lifesciences is a Public company.

  • What is Edwards Lifesciences’s stock symbol?

    The ticker symbol for Edwards Lifesciences is EW.

  • What is the current stock price of Edwards Lifesciences?

    As of 18-Jun-2024 the stock price of Edwards Lifesciences is $88.52.

  • What is the current market cap of Edwards Lifesciences?

    The current market capitalization of Edwards Lifesciences is $53.3B.

  • What is Edwards Lifesciences’s current revenue?

    The trailing twelve month revenue for Edwards Lifesciences is $6.14B.

  • Who are Edwards Lifesciences’s competitors?

    Integra Lifesciences, Stryker, Boston Scientific, Zimmer Biomet Holdings, and Teleflex are some of the 45 competitors of Edwards Lifesciences.

  • What is Edwards Lifesciences’s annual earnings per share (EPS)?

    Edwards Lifesciences’s EPS for 12 months was $2.33.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »